Sarcopenic obesity and severity of chronic venous disease in postmenopausal women

Authors

DOI:

https://doi.org/10.30978/GS-2024-2-47

Keywords:

postmenopausal women, chronic venous disease, chronic venous insufficiency, sarcopenia, sarcopenic obesity

Abstract

Sarcopenic obesity (SO) is a functional and clinical condition that is characterised by the simultaneous existence of sarcopenia and excess adipose tissue. This condition may be one of the pathogenetic factors for chronic venous disease (CVD) of the lower extremities and chronic venous insufficiency (CVI), due to impaired muscle venous pump function. Furthermore, obesity is considered a risk factor for these conditions.

Objective — to investigate the association of sarcopenia and sarcopenic obesity with the severity of chronic venous disease in postmenopausal women.

Materials and methods. The study included 117 postmenopausal women who were divided into two groups: Group I — 87 (74.4%) women with CVD, and Group II—30 (25.6%) women without any signs of CVD. Within Group I, two subgroups were distinguished based on the class of CVD as defined by the CEAP classification system. Subgroup IA consisted of 45 women (51.7%) with CVD classes 1 and 2, which correspond to compensated chronic venous insufficiency (CVI). Subgroup IB included 42 women (48.3%) with CVD classes 3, 4, and 5, indicating subcompensated or decompensated CVI. The measurement of fat and lean mass was conducted using dual‑energy X‑ray absorptiometry with the Hologic device (Discovery WI, USA, 2015). The presence of sarcopenia was determined by the skeletal muscle assessment index ASM/height2, where ASM is the total appendicular skeletal muscle mass of the legs and arms. Sarcopenia was diagnosed when the value of ASM/height2 was <6.0 kg/m2. The diagnosis of SO was made in patients with sarcopenia and a body mass index >25 kg/m2.

Results. The mean age of women was 67.32±9.12 years (46—86 years), the mean body mass index was 29.1±6.0 kg/m2 (18.4—50.1 kg/m2), and BMI/height2 was 6.72±0.864 kg/m2. Women in Group I had lower values of BMI/height2 (6.63±0.72 kg/m2) than women in Group II (6.97±1.0 kg/m2, p=0.056). Sarcopenia was detected in 27 (23.1%) women, and SO in 17 (14.5%). There was no statistically significant difference between the groups in the frequency of sarcopenia: in Group I, 5 (16.7%) women had sarcopenia, in Group II — 22 (25.3%), (p=0.334). The proportion of patients with SO in Group I was statistically significantly larger compared to Group II — 18.4 and 3.3% (p=0.044). There was an increase in the proportion of women with sarcopenia and SO with increasing severity of CVI: 8 (17.8%) patients in subgroup IA and 14 (33.3%) in subgroup IB had sarcopenia (p=0.095), and 4 (8.94%) and 12 (28.6%) had SO, respectively (p=0.018).

Conclusions. Postmenopausal women with CVD were more likely to have SO (18.4%) compared to patients without CVD (3.3%, p=0.044). Postmenopausal women with subcompensated and decompensated CVI were more likely to have SO (12 (28.6%)) than women with compensated CVI (4 (8.94%, p=0.018, odds ratio 6.54, 95% confidence interval 0.83—51.58). Menopausal women with CVD were more likely to have sarcopenia and had a higher incidence of subcompensated and decompensated CVI compared to women without sarcopenia, but the difference was not statistically significant.

 

References

Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998 Apr 15;147(8):755-63. http://doi.org/10.1093/oxfordjournals.aje.a009520. Erratum in: Am J Epidemiol 1999 Jun 15;149(12):1161. PMID: 9554417.

Benigni JP, Cazaubon M, Tourneroche A, Achhammer I, Mathieu M. Is obesity an aggravating factor in chronic venous disease? Results of a French epidemiological study in male patients. Int Angiol. 2006 Sep;25(3):297-303. PMID: 16878080.

Cesari M, Leeuwenburgh C, Lauretani F, Onder G, Bandinelli S, Maraldi C, Guralnik JM, Pahor M, Ferrucci L. Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti study. Am J Clin Nutr. 2006 May;83(5):1142-8. http://doi.org/10.1093/ajcn/83.5.1142. PMID: 16685058; PMCID: PMC2668161.

Danielsson G, Eklof B, Grandinetti A, Kistner RL. The influence of obesity on chronic venous disease. Vasc Endovascular Surg. 2002 Jul-Aug;36(4):271-6. http://doi.org/10.1177/153857440203600404. PMID: 15599477.

Demir S, Şahin H, Baran Ç, Gelişen M İ. Body mass index and primary chronic venous disease. Turkiye Klinikleri Cardiovascular Sciences. 2016;28:3. http://doi.org/10.5336/cardiosci.2016-53313.

Ebrahimi H, Amanpour F, Bolbol Haghighi N. Prevalence and risk factors of varicose veins among female hairdressers: a cross sectional study in north-east of Iran. J Res Health Sci. 2015 Spring;15(2):119-23. PMID: 26175296.

Eklöf B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, Meissner MH, Moneta GL, Myers K, Padberg FT, Perrin M, Ruckley CV, Smith PC, Wakefield TW; American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004 Dec;40(6):1248-52. http://doi.org/10.1016/j.jvs.2004.09.027. PMID: 15622385.

Eskici H, Engin M, Eris C, Aydın U, Ata Y, Yavuz Ş. Investigation of the effect of visceral adiposity index on venous clinical severity score in patients with chronic venous insufficiency. Vascular. 2023 Nov 6:17085381231214818. http://doi.org/10.1177/17085381231214818. Epub ahead of print. PMID: 37931595.

Feodor T, Baila S, Mitea IA, Branisteanu DE, Vittos O. Epidemiology and clinical characteristics of chronic venous disease in Romania. Exp Ther Med. 2019 Feb;17(2):1097-1105. http://doi.org/10.3892/etm.2018.7059. Epub 2018 Dec 5. PMID: 30679980; PMCID: PMC6327587.

Gao Q, Mei F, Shang Y, Hu K, Chen F, Zhao L, Ma B. Global prevalence of sarcopenic obesity in older adults: A systematic review and meta-analysis. Clin Nutr. 2021 Jul;40(7):4633-4641. http://doi.org/10.1016/j.clnu.2021.06.009. Epub 2021 Jun 21. PMID: 34229269.

International Union of Phlebology. Vein consult program (Observational, multicentric, descriptive survey of chronic venous disease). Eur J Vasc Endovasc Surg. 1996;12:487-92.

Kim TN, Yang SJ, Yoo HJ, Lim KI, Kang HJ, Song W, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes (Lond). 2009 Aug;33(8):885-92. http://doi.org/10.1038/ijo.2009.130. Epub 2009 Jun 30. PMID: 19564878.

Kostromin G, Povoroznyuk V. Age, body composition, body mass index and chronic venous diseases in postmenopausal women. International Journal of Medical and Health Sciences. 2020;(2):94-8.

Limpawattana P, Inthasuwan P, Putraveephong S, Boonsawat W, Theerakulpisut D, Sawanyawisuth K Sarcopenia in chronic obstructive pulmonary disease: A study of prevalence and associated factors in the Southeast Asian population. Chron Respir Dis. 2018 Aug;15(3):250-7. http://doi.org/10.1177/1479972317743759.

Ma J, Hwang SJ, McMahon GM, Curhan GC, Mclean RR, Murabito JM, Fox CS. Mid-adulthood cardiometabolic risk factor profiles of sarcopenic obesity. Obesity (Silver Spring). 2016 Feb;24(2):526-34. http://doi.org/10.1002/oby.21356. PMID: 26813531.

Mahapatra S, Ramakrishna P, Gupta B, Arumalla A, Para MA. Correlation of obesity and comorbid conditions with chronic venous insufficiency. Results of a single-centre study. The Indian Journal of Medical Research. 2018 May; 147(5):471. do: 10.4103/ijmr.IJMR_1844_16. https://pubmed.ncbi.nlm.nih.gov/30082571/

Masik N, Stepaniuk T, Masik O. Skeletal muscle dysfunction, sarcopenia and sarcopenic obesity in patients with chronic obstructive pulmonary disease. Pain, Joints, Spine. 2022;12(1):8-15. https://doi.org/10.22141/pjs.12.1.2022.323.

Mitchell WK, Williams J, Atherton P, Larvin M, Lund J, Narici M. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol. 2012;3:260. http://doi.org/10.3389/fphys.2012.00260.

Musil D, Kaletova M, Herman J. Age, body mass index and severity of primary chronic venous disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Dec;155(4):367-71. http://doi.org/10.5507/bp.2011.054. PMID: 22336650.

Rabe E, Guex JJ, Puskas A, Scuderi A, Fernandez Quesada F; VCP Coordinators. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012 Apr;31(2):105-15. PMID: 22466974.

Riechman SE, Schoen RE, Weissfeld JL, Thaete FL, Kriska AM. Association of physical activity and visceral adipose tissue in older women and men. Obes Res. 2002 Oct;10(10):1065-73. http://doi.org/10.1038/oby.2002.144. PMID: 12376588.

Rosenberg IH, Roubenoff R. Stalking sarcopenia. Ann Intern Med. 1995 Nov 1;123(9):727-8. http://doi.org/10.7326/0003-4819-123-9-199511010-00014. PMID: 7574231.

Ryan AS, Nicklas BJ. Age-related changes in fat deposition in mid-thigh muscle in women: relationships with metabolic cardiovascular disease risk factors. Int J Obes Relat Metab Disord. 1999 Feb;23(2):126-32. http://doi.org/10.1038/sj.ijo.0800777. PMID: 10078845.

Scott D, Chandrasekara SD, Laslett LL, Cicuttini F, Ebeling PR, Jones G. Associations of sarcopenic obesity and dynapenic obesity with bone mineral density and incident fractures over 5-10 years in community-dwelling older adults. Calcif Tissue Int. 2016;99:30-42. http://doi.org/10.1007/s00223-016-0123-9.

Seliverstov EI, Avakyants IP, Nikishkov AS, Zolotukhin IA. Epidemiology of Chronic Venous Disease. Flebology. 2016; 1:297-303.

Torii Y, Kusunose K, Zheng R, et al. Association between Sarcopenia/lower muscle mass and short-term regression of deep vein thrombosis using direct oral anticoagulants. Int Heart J. 2020 Jul 30;61(4):787-94. http://doi.org/10.1536/ihj.20-032.

Vlajinac HD, Marinkovic JM, Maksimovic MZ, Matic PA, Radak DJ. Body mass index and primary chronic venous disease : a cross-sectional study. Eur J Vasc Endovasc Surg. 2013 Mar;45(3):293-8. http://doi.org/10.1016/j.ejvs.2012.12.011.

Vuylsteke ME, Thomis S, Guillaume G, Modliszewski ML, Weides N, Staelens I. Epidemiological study on chronic venous disease in Belgium and Luxembourg: prevalence, risk factors, and symptomatology. Eur J Vasc Endovasc Surg. 2015 Apr;49(4):432-9. http://doi.org/10.1016/j.ejvs.2014.12.031. Epub 2015 Feb 18. PMID: 25701071.

Wagenaar CA, Dekker LH, Navis GJ. Prevalence of sarcopenic obesity and sarcopenic overweight in the general population: the lifelines cohort study. Clin Nutr. 2021;40:4422-9. http://doi.org/10.1016/j.clnu.2021.01.005.

Wei S, Nguyen TT, Zhang Y, Ryu D, Gariani K. Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management. Front Endocrinol (Lausanne). 2023 Jun 30;14:1185221. http://doi.org/10.3389/fendo.2023.1185221. PMID: 37455897; PMCID: PMC10344359.

Willenberg T, Schumacher A, Amann-Vesti B, Jacomella V, Thalhammer C, Diehm N. Impact of obesity on venous hemodynamics of the lower limbs. J Vasc Surg. 2010 Sep; 52(3):664-8. http://doi.org/10.1016/j.jvs.2010.04.023.

Zhang X, Xie X, Dou Q, et al. Association of sarcopenic obesity with the risk of all-cause mortality among adults over a broad range of different settings: a updated meta-analysis. BMC Geriatr. 2019;19:183. http://doi.org/10.1186/s12877-019-1195-y

Downloads

Published

2024-06-30

How to Cite

1.
Kostromin G, Balaban O, Honza R. Sarcopenic obesity and severity of chronic venous disease in postmenopausal women. ЗХ [Internet]. 2024Jun.30 [cited 2024Nov.13];(2):47-53. Available from: http://generalsurgery.com.ua/article/view/308063

Issue

Section

Original Research